Feel like taking your creativity level… a bit higher? Available for booking beginning this week, Seth Rogen partnered with Airbnb to unveil “A High-ly Creative Retreat,” providing a unique getaway in Los Angeles with ceramic activities.

The retreat features a ceramic studio with Rogen’s own handmade pottery, a display of his cannabis and lifestyle company Houseplant’s unique Housegoods, as well as mid-century furnishings, and “sprawling views of the city.”

The Airbnb is probably a lot cheaper than you think: Rogen will host three, one-night stays on February 15, 16, and 17 for two guests each for just $42—one decimal point away from 420—with some restrictions. U.S. residents can book an overnight stay at Rogen’s Airbnb beginning Feb. 7, but book now, because it’s doubtful that open slots will last.

“I don’t know what’s more of a Houseplant vibe than a creative retreat at a mid-century Airbnb filled with our Housegoods, a pottery wheel, and incredible views of LA,” Rogen said. “Add me, and you’ll have the ultimate experience.”

According to the listing, and his Twitter account, Rogen will be there to greet people and even do ceramics together.

“I’m teaming up with Airbnb so you (or someone else) can hang out with me and spend the night in a house inspired by my company,” Rogen tweeted recently.

Guests will be provided with the following activities:

• Get glazed in the pottery studio and receive pointers from Rogen himself!
• Peruse a selection of Rogen’s own ceramic masterpieces, proudly displayed within the mid-century modern home.
• Relax and revel in the sunshine of the space’s budding yard.
• Tune in and vibe out to a collection of Houseplant record sets with specially curated tracklists by Seth Rogen & Evan Goldberg and inspired by different cannabis strains. Guests will get an exclusive first listen to their new Vinyl Box Set Vol. 2.
• Satisfy cravings with a fully-stocked fridge for after-hours snacks.

Airbnb plans to join in on Rogen’s charity efforts, including his non-profit Hilarity for Charity, focusing on helping people living with Alzheimer’s disease.

“In celebration of this joint effort, Airbnb will make a one-time donation to Hilarity for Charity, a national non-profit on a mission to care for families impacted by Alzheimer’s disease, activate the next generation of Alzheimer’s advocates, and be a leader in brain health research and education,” Airbnb wrote.

In 2021, Rogen launched Houseplant, his cannabis and lifestyle company, in the U.S. But the cannabis brand’s web traffic was so high that the site crashed. Houseplant was founded by Rogen and his childhood friend Evan Goldberg, along with Michael Mohr, James Weaver, and Alex McAtee.

Yahoo! News reports, however, that Airbnb does not (cough, cough) allow cannabis on the premises of listings. The listing, however, will be filled with goods from Houseplant. Houseplant also sells luxury paraphernalia with a “mid-century modern spin.”

Seth Rogen recently invited Architectural Digest to present a tour of the Houseplant headquarters’ interior decor and operations. Houseplant’s headquarters is located in a 1918 bungalow in Los Angeles. Architectural Digest describes it as “Mid-century-modern-inspired furniture creates a cozy but streamlined aesthetic.”

People living in the U.S. can request to book stays at airbnb.com/houseplant. Guests are responsible for their own travel to and from Los Angeles, California and comply with applicable COVID-19 rules and guidelines. 

See Rogen’s listing on the Airbnb site.

If you can’t find your way in, Airbnb provides over 1,600 other creative spaces available around the globe.

The post Seth Rogen’s ‘High-ly Creative Retreat’ Airbnb Begins Booking appeared first on High Times.

The post Seth Rogen’s ‘High-ly Creative Retreat’ Airbnb Begins Booking appeared first on Paradise Found.

The University of California, Davis announced this week that it is launching a new institute that aims to “advance basic knowledge about the mechanisms of psychedelics and translate it into safe and effective treatments for diseases such as depression, post-traumatic stress disorder, addiction, Alzheimer’s disease and Parkinson’s disease, among others.”

Called “the Institute for Psychedelics and Neurotherapeutics,” it will “bring together scientists across a range of disciplines and partner with the pharmaceutical industry to ensure that key discoveries lead to new medicines for patients,” the university said in the announcement, adding that the institute “was specifically designed to facilitate collaborations across campus.”

The institute “will be funded in part by a contribution of approximately $5 million from the deans of the College of Letters and Science and the School of Medicine, the vice chancellor for Research, and the Office of the Provost,” the school said, noting that the funding distinguishes it from other centers involved in the same field of study.

“While other psychedelic science centers have been formed across the country with gifts from philanthropists, the UC Davis institute is notable for also being supported by substantial university funds,” the university said. 

The university said that another “unique feature of the UC Davis institute will be its focus on chemistry and the development of novel neurotherapeutics.”

David E. Olson, an associate professor in the Department of Chemistry and the Department of Biochemistry and Molecular Medicine at UC Davis, has been tapped to serve as the founding director of the new institute.

“Psychedelics have a lot of therapeutic potential, but we can do better,” said Olson, whose group published a paper three years ago “describing the first nonhallucinogenic analogue of a psychedelic compound capable of promoting neuroplasticity and producing antidepressant and anti-addictive effects in preclinical models,” according to the university.

In Olson’s view, the university said, “novel molecules tailored to specific disease indications could offer substantial benefits and open doors to partnerships with industry by solving many issues currently faced by traditional psychedelics related to safety, scalability and intellectual property.”

“Psychedelics have a unique ability to produce long-lasting changes in the brain that are relevant to treating numerous conditions,” said Olson. “If we can harness those beneficial properties while engineering molecules that are safer and more scalable, we can help a lot of people.”

John A. Gray, an associate professor in the Department of Neurology, will serve as associate director. Olson and Gray authored a study in 2018 “demonstrating that psychedelics promote neuroplasticity — the growth of new neurons and formation of neural connections,” the university said in the announcement this week.

“Neuronal atrophy is a key factor underlying many diseases, and the ability of psychedelics to promote the growth of neurons and new connections in the brain could have broad therapeutic implications,” Gray said.

The university stated that the institute “will leverage the extraordinary breadth of expertise in the neuroscience community at UC Davis, which includes nearly 300 faculty members in centers, institutes and departments across the Davis and Sacramento campuses,” and that researchers “will be able to work on every aspect of psychedelic science, from molecules and cells through to human clinical trials.”

“Combining the considerable expertise of UC Davis’ pioneering basic research teams, world-class neuroscientists and our nationally recognized medical center is a formula for success that we trust will result in groundbreaking discoveries that will help patients regionally and worldwide,” Susan Murin, dean of the School of Medicine, said in the announcement this week.

The post UC Davis Launches Institute for Psychedelics and Neurotherapeutics appeared first on High Times.

The post UC Davis Launches Institute for Psychedelics and Neurotherapeutics appeared first on Paradise Found.

Could dementia and Alzheimer’s patients benefit from cannabis?

The post Colorado Cannabis Company to Study Cannabinoids’ Effect on Alzheimer’s Disease appeared first on High Times.

The post Colorado Cannabis Company to Study Cannabinoids’ Effect on Alzheimer’s Disease appeared first on Paradise Found.